These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 26719433)

  • 1. Chemotherapy-Induced Intestinal Mucosal Barrier Damage: a Cause of Falsely Elevated Serum 1,3-Beta-d-Glucan Levels?
    Prattes J; Raggam RB; Vanstraelen K; Rabensteiner J; Hoegenauer C; Krause R; Prüller F; Wölfler A; Spriet I; Hoenigl M
    J Clin Microbiol; 2016 Mar; 54(3):798-801. PubMed ID: 26719433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevation of activated platelet-dependent chemokines and soluble cell adhesion molecules in patients with hematologic malignancies and high levels of beta-D-glucan.
    Nomura S; Iishii K; Inami N; Kimura E; Urase F
    Pathophysiol Haemost Thromb; 2007; 36(1):32-9. PubMed ID: 18332612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Difficulties in using 1,3-{beta}-D-glucan as the screening test for the early diagnosis of invasive fungal infections in patients with haematological malignancies--high frequency of false-positive results and their analysis.
    Racil Z; Kocmanova I; Lengerova M; Weinbergerova B; Buresova L; Toskova M; Winterova J; Timilsina S; Rodriguez I; Mayer J
    J Med Microbiol; 2010 Sep; 59(Pt 9):1016-1022. PubMed ID: 20488937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can bacteraemia lead to false positive results in 1,3-beta-D-glucan test? Analysis of 83 bacteraemia episodes in high-risk patients for invasive fungal infections.
    Metan G; Koc AN; Ağkuş Ç; Kaynar LG; Alp E; Eser B
    Rev Iberoam Micol; 2012; 29(3):169-71. PubMed ID: 21907303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers for assessing mucosal barrier dysfunction induced by chemotherapy: Identifying a rapid and simple biomarker.
    Kong W; Wang J; Ping X; Shen J; Ni X; Liu F; Yu B; Li Y
    Clin Lab; 2015; 61(3-4):371-8. PubMed ID: 25975005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring myeloablative therapy-induced small bowel toxicity by serum citrulline concentration: a comparison with sugar permeability tests.
    Lutgens LC; Blijlevens NM; Deutz NE; Donnelly JP; Lambin P; de Pauw BE
    Cancer; 2005 Jan; 103(1):191-9. PubMed ID: 15573372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of growth factors in chemotherapy-induced intestinal mucosal damage repair.
    Xian CJ
    Curr Pharm Biotechnol; 2003 Aug; 4(4):260-9. PubMed ID: 14529428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. False-positive elevation of 1,3-beta-D-glucan caused by continuous administration of penicillin G.
    Ito S; Ashizawa M; Sasaki R; Ikeda T; Toda Y; Mashima K; Umino K; Minakata D; Nakano H; Yamasaki R; Kawasaki Y; Sugimoto M; Yamamoto C; Fujiwara SI; Hatano K; Sato K; Oh I; Ohmine K; Muroi K; Suzuki J; Hatakeyama S; Morisawa Y; Yamada T; Kanda Y
    J Infect Chemother; 2018 Oct; 24(10):812-814. PubMed ID: 30006248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucositis in the treatment of haematological malignancies.
    Niscola P; Scaramucci L; Romani C; Cupelli L; Tendas A; Dentamaro T; Ales M; Giovannini M; Piccioni D; Siniscalchi A; Tolu B; Perrotti A; Keefe D; de Fabritiis P
    Ann Oncol; 2008 Sep; 19 Suppl 7():vii141-5. PubMed ID: 18790936
    [No Abstract]   [Full Text] [Related]  

  • 10. A novel non-invasive biomarker for assessment of small intestinal mucositis in children with cancer undergoing chemotherapy.
    Tooley KL; Saxon BR; Webster J; Zacharakis B; McNeil Y; Davidson GP; Butler RN
    Cancer Biol Ther; 2006 Oct; 5(10):1275-81. PubMed ID: 17012839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma citrulline level as a biomarker for cancer therapy-induced small bowel mucosal damage.
    Barzał JA; Szczylik C; Rzepecki P; Jaworska M; Anuszewska E
    Acta Biochim Pol; 2014; 61(4):615-31. PubMed ID: 25473654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The significance of altered gastrointestinal permeability in cancer patients.
    Melichar B; Zezulová M
    Curr Opin Support Palliat Care; 2011 Mar; 5(1):47-54. PubMed ID: 21326003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucositis in patients with hematologic malignancies: an overview.
    Niscola P; Romani C; Cupelli L; Scaramucci L; Tendas A; Dentamaro T; Amadori S; de Fabritiis P
    Haematologica; 2007 Feb; 92(2):222-31. PubMed ID: 17296572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Citrulline and albumin as biomarkers for gastrointestinal mucositis in recipients of hematopoietic SCT.
    van der Velden WJ; Herbers AH; Brüggemann RJ; Feuth T; Peter Donnelly J; Blijlevens NM
    Bone Marrow Transplant; 2013 Jul; 48(7):977-81. PubMed ID: 23334276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bloodstream infections are an improbable cause of positive serum (1,3)-β-D-glucan in hematology patients.
    Furfaro E; Mikulska M; Del Bono V; Guolo F; Minetto P; Gobbi M; Ghiso A; Bacigalupo A; Viscoli C
    Clin Vaccine Immunol; 2014 Sep; 21(9):1357-9. PubMed ID: 24990906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum diamine oxidase activity as a predictor of gastrointestinal toxicity and malnutrition due to anticancer drugs.
    Miyoshi J; Miyamoto H; Goji T; Taniguchi T; Tomonari T; Sogabe M; Kimura T; Kitamura S; Okamoto K; Fujino Y; Muguruma N; Okahisa T; Takayama T
    J Gastroenterol Hepatol; 2015 Nov; 30(11):1582-90. PubMed ID: 25968084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of oral and gastrointestinal mucositis: ESMO clinical recommendations.
    Peterson DE; Bensadoun RJ; Roila F;
    Ann Oncol; 2009 May; 20 Suppl 4():174-7. PubMed ID: 19454447
    [No Abstract]   [Full Text] [Related]  

  • 18. Implications of treatment-induced mucosal barrier injury.
    Blijlevens NM
    Curr Opin Oncol; 2005 Nov; 17(6):605-10. PubMed ID: 16224241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarkers of regimen-related mucosal injury.
    Gibson RJ; Bowen JM
    Cancer Treat Rev; 2011 Oct; 37(6):487-93. PubMed ID: 21689887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intestinal permeability in the assessment of intestinal toxicity of cytotoxic agents.
    Melichar B; Dvorák J; Hyspler R; Zadák Z
    Chemotherapy; 2005 Oct; 51(6):336-8. PubMed ID: 16224185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.